Influence of ionizing radiation on proliferation, c-myc expression and the induction of apoptotic cell death in two breast tumour cell lines differing in p53 status

References

• ALRIDGE, D. R., ARENDS M. J. and RADFORD, I. R., 1995, Increasing the susceptibility of the rat 208F fibroblast cell line to radiation-induced apoptosis does not alter is clonogenic survival dose response. British Journal of Cancer, 71, 571–577.
   Google Scholar
• BAE, I., FAN, S., BHATIA, K., KOHN, K. W., FORNACE, A. J. and O'CONNOR, P. M., 1995, Relationship between G1 arrest and stability of the p53 and p21'f1141 protein following ionizing radiation of human lymphoma cells. Cancer Research, 55, 2387–2393.
   Google Scholar
• BARTEK, J., IGGo, R., GANNON, J. and LANE, D. P., 1990, Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines. oncogene, 5, 893–899.
   PubMed Web of Science ®Google Scholar
• BELLO-FERNANDEZ, C., PACKHAM, G. and CLEVELAND, J. L., 1993, The ornithine decarboxylase gene is a transcrip-tional target of C -my c. Proceedings of the National Academy of Sciences, 90, 7804–7808.
   PubMed Web of Science ®Google Scholar
• BRACEY, T. S., MILLER, J. C. and PARASKEVA, C., 1995, Radiation induced apoptosis in human colorectal aden-oma and carcinoma cell lines can occur in the absence of wild type p53. oncogene, 10, 2391–2396.
   PubMed Web of Science ®Google Scholar
• BRACHMAN, D. G., BECKETT, M., GRAVES, D., HARAF, D., VOICES, E. and WEICHSELBAUM, R. R., 1993, p53 muta-tions do not correlate with radiosensitivity in 24 head and neck cancer cell lines. Cancer Research, 53, 3667–3669.
   PubMed Web of Science ®Google Scholar
• BUNCH, R. T., PovIRK, L. F., ORR, M. S., RANDOLPH, J. K., FORNARI, F. A. and GEWIRTZ, D. A., 1994, Influence of m-AMSA on bulk and gene-specific DNA damage and c -my c expression in MCF-7 breast tumour cells. Biochemical Pharmacology, 47, 317–329.
   PubMed Web of Science ®Google Scholar
• CHANG, W. P. and LITTLE, J. B., 1991, Delayed reproductive death in x-irradiated Chinese hamster ovary cells. International Journal of Radiation Biology, 60, 483— 496.
   Web of Science ®Google Scholar
• CHEN, A. Y. and Liu, L. F., 1994, DNA topoisomerases: essential enzymes and lethal targets. Annual Review of Pharmacology and Toxicology, 34, 191–218.
   PubMed Web of Science ®Google Scholar
• DALLA-FAVERA, R., WONG-STAAL, F. and GALLO, R. C., 1982, Onc gene amplification in promyelocytic leukemia cells of the same patient. Nature, 299, 61–63.
   PubMed Web of Science ®Google Scholar
• DENARDO, S. J., GUMERLOCK, P. H., WINTHROP, M. D., MACK, P. C., CHI, S-G., LAMBORO, K. R. et al. 1995, Yitrium-90 chimeric L6 therapy of human breast cancer in nude mice and apoptosis related messenger RNA expression. Cancer Research, 55, 5837–5841.
   Google Scholar
• EL-DEIRY, W. S., HARPER, J. W., O'CONNOR, P. M., VELCULESCU, V. E., CANMAN, C. E., JACKMAN, J. et al. 1994, WAF1/CIP1 is induced in p53 mediated G1 arrest and apoptosis. Cancer Research, 54, 1169–1174.
   Google Scholar
• ELLEDGE, R. M. and ALFRED, D. C., 1994, The p53 tumor suppressor gene in breast cancer. Breast Cancer Research and Treatment, 32, 39–47.
   PubMed Web of Science ®Google Scholar
• ESCOT, C., THEILLET, R., LIDEREAU, F., SPYRATOS, M., CHAMPEME, M. H., GEST, J. and CALLAHAN, R., 1986, Genetic alteration of the c-mycproto-oncogene in primary human breast carcinomas. Proceedings of the N ational Academy of Sciences, USA, 83, 4834–4838.
   PubMed Web of Science ®Google Scholar
• EVAN, G. I., WYLLIE, A. H., GILBERT, C. S., LITTLEWOOD, T. D., LAND, H., BROOKS, M., WALTERS, C. M., PENN L. Z. and HANCOCK, D. C., 1992, Induction of apoptosis in fibroblasts by C -my c protein. Cell, 69, 119–128.
   Google Scholar
• FAN., S., EL-DEIRY, W. S., BAE, I., FREEMAN, J., JONDLE, D., BHATIA, K., FORNACE, A. J., MAGRATH I., KOHN, K. W.and O'CONNOR, P. M., 1994, p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Cancer Research, 54, 5824–5830.
   Google Scholar
• FAN, S., SMITH, M. L., RIVET, D. J., DUBA, D., ZHAN, Q., KOHN, K. W., FORNACE, A. J. and O'CONNOR, P. M.7 1995, Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline. Cancer Research, 55, 1649–1654.
   Google Scholar
• FORNARI, F. A., JARVIS, W. D., GRANT, S., ORR, M. S., RANDOLPH, J. K., WHITE, F. K. H., MUMAW, V. R., LovINGs, E. T., FREEMAN, R. H. and GEWIRTZ, D. A., 1994, Induction of differentiation and non-apoptotic cell death associated with nascent DNA fragmentation and reduced c-myc expression in MCF-7 human breast tumor cells exposed to a therapeutically relevant concentration of doxorubicin. Cell Growth and D lfferentiation, 5, 723–733.
   Google Scholar
• FORNARI, F. A., JARVIS, W. D., ORR, M. S., RANDOLPH, J. K., GRANT, S. and GEWIRTZ, D. A., 1996, Growth arrest via down-regulation of c-myc expression in MCF-7 breast tumor cells after acute exposure to doxorubicin. Biochemical Pharmacology, 51, 931 —940.
   Web of Science ®Google Scholar
• GARTE, S. J., BURNS, F. J., ASHKENAZI-KIMMEL, T., FELBER, M. and SAWEY, M. J., 1990, Amplification of the c-myc oncogene during progression of radiation induced rat skin tumors. Cancer Research, 50, 3073–3077.
   Google Scholar
• GAVRIELI, Y., SHERMAN, Y. and BEN-SASSON, S. A" 1992, Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. Journal of Cell Biology, 119, 493–501.
   Google Scholar
• GERSCHENSON, L. E. and ROTELLO, R. J.7 1992, Apoptosis: a different type of cell death. FASE B Journal, 6, 2450–2455.
   PubMed Web of Science ®Google Scholar
• GEWIRTZ, D. A., FORNARI, F. A., ORR, M. S., RANDOLPH, J. K., PovIRK L. and BUNCH, R. T., 1993, Dissociation between bulk damage to DNA and the antiproliferative activity of teniposide in the MCF-7 breast tumor cell line: evidence for induction of gene-specific damage and alterations in gene expression. Cancer Research, 53, 3547–3554.
   Google Scholar
• GUDAS, J., NGUYEN, H., LI, T., HILL, D. and COWAN, K. H., 1995, Effect of cell cycle, wild-type p53 and DNA damage on p21wa1/QP1 expression in human breast epithelial cells. oncogene, 11, 253–261.
   PubMed Web of Science ®Google Scholar
• GUDAS, J. M., NGUYEN, H., LI, T., SADZEWICZ, L., ROBEY, R., WomKowmu, K. and COWAN, K. H., 1996, Drug-resistant breast cancer cells frequently retain expression of a functional wild-type p53 protein. E arcinogenesis, 17, 1417–1427.
   PubMed Web of Science ®Google Scholar
• HENNEKING, H. and EICK, D., 1994, Mediation of C-myc induced apoptosis by p53. Science, 265, 2091–2093.
   PubMed Web of Science ®Google Scholar
• JARVIS, W. D., KOLESNICK, R. N., FORNARI, F. A., TRAYLOR, R. S., GEWIRTZ, D. A. and GRANT, S., 1994, Induction of apoptotic DNA damage and cell death by activation of the sphingomyelinase pathway. Proceedings of the National Academy of Sciences, USA, 91, 73–77.
   PubMed Web of Science ®Google Scholar
• JUNG, M., NOTARIO, V. and DRITSCHILO, A" 1992, Mutation in the p53 gene in radiation sensitive and resistant human squamous carcinoma cells. Cancer Research, 52, 6390–6393.
   Google Scholar
• KARN, J., WATSON, J. V., LOWE, A. D., GREEN, S. M. and VEDECKIS, W., 1989, Regulation of cell cycle duration by C -my c levels. 0 ncogene, 4, 773— 787.
   Google Scholar
• KASTAN, M. B., ONYEKWERE, 0., SIDRANSKY, D., VOGELSTEIN, B. and CRAIG, R. W., 1991, Participation of p53 protein in the cellular response to DNA damage. Cancer Research, 51, 6304–6311.
   Google Scholar
• KATAYOSE, D., WERSTO, R., COWAN K.H. and SETH, P.7 1995, Effects of a recombinant adenovirus expressing WAF1/Cipl on cell growth, cell cycle, and apoptosis. Cell Growth and D erentiation, 6, 1207–1212.
   Google Scholar
• KREIPE, H., FEIST, H., FISCHER, L., FELGNER, J., HEIDORN, K., METTLER, L. and PANVARESCH, R.7 1993, Amplification of-my c but not c-erbB- 2 is associated with high proliferat-ive activity in breast cancer. Cancer Research, 53, 1956–1961.
   Google Scholar
• KUERBITZ, S. J., PUNKETT, B. S., WALSH, W. V. and KASTAN, M. B., 1992, Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proceedings of the National Academy of Sciences, USA, 89, 7491 —7495.
   Web of Science ®Google Scholar
• LANGLEY, R. E., PALAYOOR, S. T., COLEMAN, C. N. and BUMP, E. A., 1994. Radiation-induced apoptosis in F9 tetracar-cinoma cells. International Journal of Radiation Biology, 65, 605–610.
   PubMed Web of Science ®Google Scholar
• LEBREQUE, S. and MATLUSHEWS, G. J.7 1995, Viability of wild-type p53 containing and p53 deficient tumor cells follow-ing anticancer treatment: the use of human papilloma virus E6 to target p53. oaragene, 11, 387–392.
   Google Scholar
• LEE, J. M. and BERNSTEIN, A.7 1993, p53 mutations increase resistance to ionizing radiation. Proceedings of the National Academy of Sciences, USA, 90, 5742–5746.
   Google Scholar
• LEVY, N., YONISH-ROUACH, E., OREN, M. and KIMCHI, A.71993, Complementation by wild-type p53 of interleukin-6 effects on MI cells: induction of cell-cycle exit and cooperativity with C -my c suppression. Molecular and Cellular Biology, 13, 7942–7952.
   Google Scholar
• LING, C. C., GUO, M., CHEN, C. H. and DELOHEREY, T.7 1995, Radiation induced apoptosis: effects of cell age and dose fractionation. Cancer Research, 55, 5207–5212.
   Google Scholar
• LOWE, S. W., BODIS, S., MCCLATCHEY, A., REMINGTON, L., RULEY, H. E., FISHER, D. E., HousmAN, D. E. and JACKS, T., 1994, p53 status and the efficacy of cancer therapy in vivo. Science, 266, 807–810.
   PubMed Web of Science ®Google Scholar
• LOWE, S. W., RULEY, H. E., JACKS, T. and HousmAN, D. E., 1993a, p53 dependent apoptosis modulates the cytotox-icity of anticancer drugs. Cell, 74, 957–967.
   PubMed Web of Science ®Google Scholar
• LOWE, S. W., SCHMITT, E. M., SMITH, S. W., OSBORNE, B. A. and JACKS, T., 1993b, p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature, 362, 847–849.
   PubMed Web of Science ®Google Scholar
• MANIATIS, T., FRITSCH, E. F. and SAMBROOK, J.7 1982. Molecular Cloning. A Laboratory Manual. (Cold Spring Harbor: Cold Spring Harbor Laboratory).
   Google Scholar
• MATIANI-COSTANTINI, R., ESCOT, C., THEILLET, C., GENTILE, A., MERLO, G., LIDEREAU, R. and CALLAHAN, R.7 1988, In-situ my c expression and genomic status of the c-myr locus in infiltrating ductal carcinoma of the breast. Cancer Research, 49, 199–205.
   Google Scholar
• MCILWERTH, A. J., VASEY, P. A., Ross, G. W. and BROWN, R.7 1994, Cell cycle arrest and radiosensitivity in human tumor cells; dependence on wild-type p53 for radiosensit-ivity. Cancer Research, 54, 3718–3722.
   Google Scholar
• MOBERG, K. H., TYNDALL, W. A. and HALL, D. J.7 1992, Wild type p53 represses transcription from the c-myc promoter in a human glial cell line. Journal of Cellular Biochemistry, 49, 208–215.
   PubMed Web of Science ®Google Scholar
• MOTHERSILL, C., SEYMOUR, C. B., HARNEY, J. and HENNESSY, T. P., 1994, High levels of stable p53 protein and the expression of c-myr in cultured human epithelial tissue cells after cobalt-60 irradiation. Radiation Research, 137, 317–322.
   PubMed Web of Science ®Google Scholar
• NAMBA, H., HARA, T., TUKAZAKI, T., MIGITA, K., ISHIKAWA, N., ITo, K., NAGATAKI, S. and YASHAMITA, 5.7 1995, Radiation induced G1 arrest is selectively mediated by the p53-WAF1/Cipl pathway in human thyroid cells. Cancer Research, 55, 2075–2080.
   Google Scholar
• OBERHAMMER, F., WILSON, J. W., DIVE, C., MORRIS, I. D., HICKMAN, J. A., WAKELING, A. E., WALKER, P. R. and SIKORSKA, M., 1993, Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO Journal, 12, 3679–3684.
   PubMed Web of Science ®Google Scholar
• O'CONNOR, P. M., JACKMAN, J., JONDLE, D., BHATA, K., MAGRATH, I. and KOHN, K. W., 1993, Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensit-ivity of Burkitt's Lymphoma Cell lines. Cancer Research, 53, 4776–4780.
   Google Scholar
• OSHEROFF, N., 1989, Biochemical basis for the interaction of Type I and Type II topoisomerases with DNA. Pharmacology and Therapeutics, 41, 223–241.
   PubMed Web of Science ®Google Scholar
• PACKHAM, G. and CLEVELAND, J. L.7 1995, The role of ornithine decarboxylase in c-myr induced apoptosis. Current Topics in Microbiology and Immunology, 194, 283–290.
   PubMedGoogle Scholar
• PALAYOOR, S. T., MACKLIS, R. M., BUMP, E. A. and COLEMAN, C. N., 1995, Modulation of radiation induced apoptosis and G2/M block in murine T-Lymphoma cells. Radiation Research, 141, 235–243.
   PubMed Web of Science ®Google Scholar
• PERRY, R. R., KANG Y. and GREAyEs, B., 1995, Effects of tamoxifen on growth and apoptosis of estrogen-dependent and -independent human breast cancer cells. Annals of Surgical Oncology, 2, 238–245.
   Google Scholar
• PRASAD, A. V., MOLLAN, N., CHANDRASEKAR, B. and MELTZ, M. L., 1995, Induction of immediate early genes by low dose ionizing radiation. Radiation Research, 143, 263–272.
   PubMed Web of Science ®Google Scholar
• RADFORD, I. J., MURPHY, T. K., RADLEV, J. M. and ELLIS, S. L., 1994, Radiation response of mouse lymphoma and melanoma cells Part II. Apoptotic death is shown in all Cell lines examined. International J ournal of Radiation Biology, 65, 217–277.
   PubMed Web of Science ®Google Scholar
• RAMQVIST, T., MAGNUSSON, K. P., WANG, Y., SZEKELY, L., KLEIN, G. and WIMAN, K. G., 1993, Wild-type p53 induces apoptosis in a Burkitt Lymphoma (BL) line that carries mutant p53. oaragene, 8, 1495–1500.
   Google Scholar
• RUSSELL, K. J., WIENS, L. W., DEMERS, G. W., GALLOWAY, D. A., PToN, S. E. and GRouDINE, M., 1995, Abrogation of the G2 checkpoint results in differential radiosensitiza-tion of G1 checkpoint deficient and G1 checkpoint com-petent Cells. Cancer Research, 55, 1639–1642.
   PubMed Web of Science ®Google Scholar
• SAWEY, M. J., HOOD, A. T., BURNS, F. J. and GARTE, S. J., 1987, Amplification of c-myr and c-K-ras oncogenes in primary rat tumors induced by ionizing radiation. Molecular and Cellular Biology, 7, 932–935.
   PubMed Web of Science ®Google Scholar
• SEEWALDT V. L., JOHNSON, B. S., PARKER M. B., COLLINS S. J. and SWISSHELM K., 1995, Expression of retinoic acid receptor beta mediates retinoic acid-induced growth arrest and apoptosis in breast cancer cells. Cell Growth and Dqferentiation, 6, 1077–1088.
   PubMedGoogle Scholar
• SEKI, H., KANEGANE, H., Iwm, K., KONNO, A., OHTA, K., YACHIE, A., TANIGUCHI, N. and MIYAWAKI, T.7 1994, Ionizing radiation induces apoptotic cell death in human TCR- T and natural killer cells without detectable p53 protein. European Journal of Immunology, 24, 2914–2917.
   Google Scholar
• SETH, A., GUPTA, S. and DAVIS, R. J., 1993, Cell cycle regulation of the C-myc transcriptional domain. Molecular and Cellular Biology, 13, 4125–4136.
   PubMed Web of Science ®Google Scholar
• SHAO, Z.-M., DAWSON, M. I., LI, X. S., RISHI, A. K., SHEIKH, M. S., HAN, 4Q-X., ORDONEZ, J. V., SHROOT, B. and FONTANA, J. A. 1995, p53 independent Go/G1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells. oucagene, 11, 493–504.
   Google Scholar
• SHICHIRI, M., HANSON, K. D. and SEDIVY, J. M., 1993, Effect of c-myc expression on proliferation, quiescence and the Go to G1 transition in nontransformed cells. Cell Growth and Dqferentation, 4, 93–104.
   PubMedGoogle Scholar
• SHIU, R. P. C., WATSON, P. H. and DUBIK, C., 1993, C-myc expression in estrogen-dependent and -independent breast cancer. Clinical Chemistry, 39/2, 353–355.
   Google Scholar
• SILES, E., VILALOBOS, M., VALENZUELA, M. T., NUNEZ, M. I., GORDON, A., MCMILLAN, T. J., PEDRAZA, V. and DE ALMODOVAR, J. M. R., 1996, Relationship between p53 status and radiosensitivity in human tumor cell lines. British Journal of Cancer, 73, 581–588.
   PubMed Web of Science ®Google Scholar
• SLICHMAYER, W. J., NELSON, W. G., SLEBOS, R. J. and KASTAN, M. B., 1993, Loss of a p53 associated G1 checkpoint does not decrease cell survival following DNA damage. Cancer Research, 53, 4164–4153.
   PubMed Web of Science ®Google Scholar
• SOKOLOVA, I. A., COWAN, K. H. and SCHNEIDER, E., 1995, Ca2±/ Me+ dependent endonuclease activation is an early event in VP-16 induced apoptosis of human breast cancer MCF-7 cells in vitro. B iochimica et B iophysica Acta, 1266, 135–142.
   PubMed Web of Science ®Google Scholar
• ST CLAIR, W. H. and ST CLAIR, D. K., 1991, Effect of the Bowman—Birk protease inhibitor on the expression of oncogenes in the irradiated rat colon. cancer Research, 51, 453–4543.
   Web of Science ®Google Scholar
• STEPHENS, L. C., HUNTER, N. R., ANG, K. K., MILAS, L. and MEYN, R. E., 1993, Development of apoptosis in irradi-ated murine tumors as a function of time and dose. Radiation Research, 135, 75–80.
   PubMed Web of Science ®Google Scholar
• SUMANTRAN, V. N., EALOVEGA, M. W., NUNEZ, G., CLARKE, M. F. and WICHA, M. S., 1995, Overexpression of BCLx-s sensitizes MCF-7 cells to chemotherapy induced apoptosis. Cancer Research, 55, 2507–2510.
   PubMed Web of Science ®Google Scholar
• TEIXEIRA, C., REED, J. C. and PRATT, M. A. C., 1995, Estrogen promotes chemotherapeutic drug resistance by a mechan-ism involving Bc1-2 proto-oncogene expression in human breast cancer cells. Cancer Research, 55, 3902–3907.
   PubMed Web of Science ®Google Scholar
• THOMAS, P. S., 1980, Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proceedings of the National Academy of Sciences, USA, 77, 5201–5205.
   PubMed Web of Science ®Google Scholar
• TISHLER, R. B., CALDERWOOD, S. K., COLEMAN N. C. and PRICE, B. D., 1993, Increase in sequence specific DNA binding by p53 following treatment with chemothera-peutic DNA damaging agents. Lancer Research, 53, 2212–2216.
   Google Scholar
• TSANG, N. M., NAGASAWA, L. and LITTLE, J. B., 1995, Abrogation of p53 function by transfection of HPV-16 E6 enhances the resistance of human diploid fibroblasts to ionizing radiation. oucageue, 10, 2403–2408.
   Google Scholar
• WARTERS, T., 1992, Radiation induced apoptosis in murine T-Cell hybridoma. Cancer Research, 52, 883–890.
   PubMed Web of Science ®Google Scholar
• WATSON, P. H., PON, R. T. and Smu, R. P. C., 1991, Inhibition of c-myc expression by phosphorothioate antisense oligon-ucleotide identifies a critical role for c-myc in the growth of human breast cancer. Cancer Research, 51, 3996–4000.
   PubMed Web of Science ®Google Scholar
• WHITACRE, C. M. and BERGER, N. A., 1997, Factors affecting topotecan induced programmed cell death: adhesion pro-tects cells from apoptosis and impairs cleavage of poly(ADP-ribose) polymerase. Lancer Research, 57, 2157–2163.
   PubMed Web of Science ®Google Scholar
• WHITAKER, S. J., UNG, Y. C. and MCMILLAN, T. J., 1995, DNA double-strand break induction and rejoining as determin-ants of human tumor cell radiosensitivity. A pulsed-field gel electrophoresis study. International Journal of Radiation Biology, 67, 7–18.
   PubMed Web of Science ®Google Scholar
• WILSON, R. E., TAYLOR, S. L., ATHERTON, G. T., JOHNSTON, D., WATERS, C. M. and NORTON, J. D., 1993, Early response gene signalling cascades activated by ionizing radiation in primary human B cells. oucageue, 83, 229–3237.
   Google Scholar
• WOLOSCHAK, G. E. and CHANG-LIU, C-M., 1995, Modulation of expression of genes encoding nuclear proteins following exposure to JANUS neutrons or gamma-rays. Lancer Letters, 97, 169–175.
   Google Scholar
• YONISH-ROUACH, E., REZNITSKY, D., LOTEM, J., SACHS, L., KIMCHI, A. and OREN, M., 1991, Wild-type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin-2. Nature, 352, 345–347.
   PubMed Web of Science ®Google Scholar
• YOUNT, G. L., HASS-KOGAN, D. A., VIDAIR, C. A., HAAS, M., DEwEy, W. C. and ISRAEL, M. A., 1996, Cell cycle synchrony unmasks the influence of p53 function on radiosensitivity of human glioblastoma cells. Lancer Research, 56, 500–506.
   Google Scholar
• ZHAN, Q., CAMER, F. and FORNACE, A. J., 1993, Induction of cellular p53 activity by DNA-damaging agents and growth arrest. Molecular and Cellular Biology, 13, 4242–4250.
   PubMed Web of Science ®Google Scholar
• ZHAN, O., FAN, S., BAE, I., GUILLOUF, C., LIEBERMANN, D. A., O'CONNOR, P. M. and FORNACE, A. J., 1994, Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis. oucageue, 9, 3743–3751.
   Google Scholar
• ZHEN, W., DENAULT, C. M., LOVISCEK, K., GENG, L. and VAUGHAN, A. T. M., 1995, The relative radiosensitivity of TK6 and WI-L2-NS lymphoblastoid cells derived from a common source is primarily determined by their p53 mutational status. Mutation Research, 346, 85–92.
   PubMedGoogle Scholar